Frontiers in Cardiovascular Science Archived Talks
2020
Understanding the Complexity of T Cell Activation in Heart Failure
Pilar Alcaide, PhD
Kenneth and JoAnn G. Wellner Professor and Associate Professor of Immunology
Tufts University School of Medicine
12/8/2020
Genetic Determinants of Thrombosis
Charles Lowenstein, MD
Professor and Chief of Cardiology
Co-Director of John Hopkins Heart and Vascular Institute and Professor of Medicine
John Hopkins
12/1/2020
Heart Failure Omics: Cardiac Metabolism and Beyond
Svati Shah, MD, MHS
Professor of Medicine
Associate Dean of Genomics and Director of Precision Genomics Collaboratory
Director of Duke Adult Cardiovascular Genetics Clinic
Co-Director of Translational Research Duke Molecular Physiology Institute
Vice-Chief of Translational Research, Division of Cardiology
Duke University School of Medicine
11/24/2020
Molecular Mechanisms of Small Vessel Disease in Hypertension and CADASIL
Rhian M. Touyz, MBBCh, PhD
Professor, British Heart Foundation Chair in Cardiovascular Medicine and Director of the Institute of Cardiovascular & Medical Sciences
BHF Glasgow Cardiovascular Research Centre
University of Glasgow
11/17/2020
Pluripotent Stem Cells for Cardiovascular Engineering and Regeneration
Yibing Qyang, PhD
Associate Professor of Medicine (Cardiology) and of Pathology
Director of Yale Stem Cell Research Forum
Yale Stem Cell Center
Yale University School of Medicine
11/10/2020
cBIN1 and T-tubule Remodeling: Mechanism, Biomarker, and Therapy for Failing Hearts
Robin M. Shaw, MD, PhD
Title of speaker: Director of the Nora Eccles Harrison Cardiovascular Research and Training Institute, Nora Eccles Harrison Presidential Endowed Chair and Professor of Medicine, University of Utah
11/3/2020
Programming and Reprogramming: What does it take to make a Cardiomyocyte?
Li Qian, PhD
Associate Professor of Pathology and Laboratory Medicine
Associate Director of McAllister Heart Institute
Faculty Director of UNC Human Pluripotent Stem Cell Core
UNC School of Medicine
10/27/2020
Neuroscientific Therapies for Heart Disease
Kalyanam Shivkumar, MD, PhD
Professor of Medicine (Cardiology), Radiology, and Bioengineering
Director of the UCLA Cardiac Arrhythmia Center & EP Programs
Director & Chief of the UCLA Interventional CV Programs & Cardiac Catheterization Laboratories
David Geffen School of Medicine & UCLA Health System
Editor-in-Chief, JACC: Clinical Electrophysiology
10/20/2020
Top-down Proteomics for Cardiac Systems Biology and Precision Medicine
Ying Ge, PhD
Professor, Department of Cell and Regenerative Biology
Department of Chemistry
Director of Human Proteomics Programs
University of Wisconsin-Madison
10/6/2020
Sudden Cardiac Death: Novel Approaches to Prediction and Prevention
Sumeet S. Chugh, MD
Price Professor and Associate Director of the Smidt Heart Institute
Medical Director of the Heart Rhythm Center
Director of the Center for Cardiac Arrest Prevention
Director of the Division of Artificial Intelligence in Medicine
Department of Medicine, Cedars Sinai
9/29/2020
COVID-19 Demographics Update
Robert K. Jackler, MD
Sewall Professor and Chair
Dept of Otolaryngology—Head & Neck Surgery
Stanford University School of Medicine
COVID-19 Cardiovascular Disease
Masataka Nishiga, MD, PhD
Postdoctoral Research Fellow
Joseph Wu Lab, Cardiovascular Institute
Stanford University School of Medicine
9/22/2020
Genes Predisposing to Thoracic Aortic Disease: Insight into Molecular Pathogenesis
Dianna M. Milewicz, MD, PhD
President George H.W. Bush Chair of Cardiovascular Medicine
Vice Chair of the Department of Internal Medicine
Director of the Division of Medical Genetics
Director of the Medical Scientist Training Program
Director of the John Ritter Research Program
University of Texas Health Science Center at Houston
McGovern Medical School
9/15/2020
Myeloid Cells and Endogenous Retroviral Elements in Pulmonary Arterial Hypertension
Marlene Rabinovitch, MD
Dwight and Vera Dunlevie Professor in Pediatric Cardiology
Stanford University
6/16/2020
Cell Therapy: Clinical Evidence and Scientific Advances
Buddhadeb Dawn, MD
Professor and Chairman
Department of Internal Medicine and Chief
Division of Cardiovascular Medicine
University of Nevada
Las Vegas School of Medicine
6/9/2020
Crucial Applications of Single Cell Gene Expression and Immune Profiling for Infectious Disease Research
Brian R. Fritz, PhD
Associate Director
Strategic Market Development & Programs
Immunology Segment Marketing
10x Genomics
6/2/2020
Epigenetic Mechanisms in Heart Failure
Gianluigi Condorelli, MD, PhD
Professor of Cardiology and Director
Post-Graduate School of Cardiology
Humanitas University and Head
Department of Cardiovascular Medicine
Humanitas Research Hospital
5/26/2020
Part I: Targeting Inflammation in Hypertension
Part II: Why Publish in Cardiovascular Research - Basic and Translational Journal of the ESC
Tomasz J. Guzik, MD, PhD
Regius Professor of Physiology and Cardiovascular Medicine
Institute of Cardiovascular & Medical Sciences
BHF Glasgow Cardiovascular Research Centre
Queen Elizabeth University Hospital
University of Glasgow
5/19/2020
Signalosomes and Pathological Cardiac Remodeling
Michael Kapiloff, MD, PhD
Associate Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Stanford University
5/12/2020
Immune Checkpoints in Large Vessel Vasculitis
Cornelia Weyand, MD, PhD
Professor of Medicine (Immunology and Rheumatology)
Stanford University
4/28/2020
A Two-Hit Model of Pulmonary Arterial Hypertension
Mark Robert Nicolls, MD
Chief, Division of Pulmonary
Allergy & Critical Care Medicine and Endowed Chair
Stanford Professor of Pulmonary & Critical Care Medicine
Stanford University
4/21/2020
Battle of the Weight Loss Diets: Is Anyone Winning (at Losing)?
Christopher Gardner, PhD
Rehnborg Farquhar Professor
Stanford Prevention Research Center
Stanford University
4/14/2020
Inside the American Heart Association’s Research Enterprise: Grant Funding and Other Opportunities
Glenn Dillon, PhD
Director of Research Operations
American Heart Association
4/7/2020
Using Patient iPSCs to Generate Safe and Effective Drugs for Heart Disease and Cancer
Mark Mercola, PhD
Professor of Medicine (Cardiovascular)
Stanford Cardiovascular Institute
Stanford University
3/31/2020
iPSCs - Heart and the Gut
Maria I. Kontaridis, PhD
Director of Research
Gordon K. Moe Professor and Chair
Biomedical Research and Translational Medicine
Masonic Medical Research Institute
Associate Professor of Medicine, Part-time
Beth Israel Deaconess Medical Center
Harvard Medical School
3/3/2020
Therapeutic Effects of Apelin Signaling on Cardiovascular Aging
Jayakumar Rajadas, PhD
Assistant Professor (Research) of Medicine (Pulmonary and Critical Medicine)
Stanford University
2/25/2020
Bridging the Translational Divide in Hypertrophic Cardiomyopathy
Sharlene M. Day, MD
Clinical Associate Professor of Medicine
University of Pennsylvania
1/28/2020
Mechanisms in Cardiac Maturation and Diseases: Discovery to Therapy
Yibin Wang, PhD
Professor of Molecular Medicine in the David Geffen School of Medicine at UCLA Chair of Cardiovascular Theme at UCLA Vice Chair for Research and Director of the Division of Molecular Medicine in the Department of Anesthesiology and Perioperative Medicine
1/14/2020